Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder

Clinical trial NCT00962104 · COMPLETED

Trial details

NCT number: NCT00962104
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2009-08-01
Primary completion: 2011-02-01
Enrollment: 391

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.